Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Up 50.0% in October

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) saw a large growth in short interest in October. As of October 15th, there was short interest totalling 9,900 shares, a growth of 50.0% from the September 30th total of 6,600 shares. Based on an average daily volume of 5,200 shares, the days-to-cover ratio is presently 1.9 days.

Fidelity Disruptive Medicine ETF Trading Up 0.6 %

Shares of NASDAQ:FMED opened at $25.92 on Tuesday. Fidelity Disruptive Medicine ETF has a 1-year low of $19.88 and a 1-year high of $26.68. The firm has a market capitalization of $54.43 million, a PE ratio of 35.73 and a beta of 0.94. The business’s 50 day moving average is $25.98 and its 200-day moving average is $24.86.

Institutional Trading of Fidelity Disruptive Medicine ETF

A hedge fund recently raised its stake in Fidelity Disruptive Medicine ETF stock. Wealth Enhancement Advisory Services LLC increased its stake in shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 6.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 496,857 shares of the company’s stock after buying an additional 29,339 shares during the quarter. Wealth Enhancement Advisory Services LLC owned 23.44% of Fidelity Disruptive Medicine ETF worth $12,680,000 at the end of the most recent reporting period.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.